1. Home
  2. NVCR vs FIHL Comparison

NVCR vs FIHL Comparison

Compare NVCR & FIHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • FIHL
  • Stock Information
  • Founded
  • NVCR 2000
  • FIHL 2014
  • Country
  • NVCR Jersey
  • FIHL Bermuda
  • Employees
  • NVCR N/A
  • FIHL N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • FIHL
  • Sector
  • NVCR Health Care
  • FIHL
  • Exchange
  • NVCR Nasdaq
  • FIHL Nasdaq
  • Market Cap
  • NVCR 1.8B
  • FIHL 2.1B
  • IPO Year
  • NVCR 2015
  • FIHL 2023
  • Fundamental
  • Price
  • NVCR $17.49
  • FIHL $17.43
  • Analyst Decision
  • NVCR Buy
  • FIHL Buy
  • Analyst Count
  • NVCR 5
  • FIHL 9
  • Target Price
  • NVCR $26.60
  • FIHL $20.50
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • FIHL 302.1K
  • Earning Date
  • NVCR 10-30-2024
  • FIHL 11-12-2024
  • Dividend Yield
  • NVCR N/A
  • FIHL 2.30%
  • EPS Growth
  • NVCR N/A
  • FIHL N/A
  • EPS
  • NVCR N/A
  • FIHL 3.82
  • Revenue
  • NVCR $549,964,000.00
  • FIHL $2,151,300,000.00
  • Revenue This Year
  • NVCR $16.23
  • FIHL N/A
  • Revenue Next Year
  • NVCR $6.09
  • FIHL $13.62
  • P/E Ratio
  • NVCR N/A
  • FIHL $4.55
  • Revenue Growth
  • NVCR 8.33
  • FIHL N/A
  • 52 Week Low
  • NVCR $10.87
  • FIHL $11.55
  • 52 Week High
  • NVCR $24.74
  • FIHL $20.53
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • FIHL 46.22
  • Support Level
  • NVCR $15.61
  • FIHL $17.24
  • Resistance Level
  • NVCR $17.31
  • FIHL $17.74
  • Average True Range (ATR)
  • NVCR 1.29
  • FIHL 0.34
  • MACD
  • NVCR 0.05
  • FIHL -0.04
  • Stochastic Oscillator
  • NVCR 11.59
  • FIHL 28.79

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a global (re)insurance company. It classify the business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.

Share on Social Networks: